Global Conjugate Vaccines Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 16-Oct-2018
No. of pages: 131

Conjugate vaccines refer to those vaccines that contain bacterial capsule polysaccharide or the antigen attached or conjugated to a protein.

Scope of the Report:

This report focuses on the Conjugate Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

This protein has a key role in enhancing the immunogenic property of the polysaccharide. These vaccines are mainly used to immunize infants and children against invasive disease caused by Hib bacteria, H. influenzae, Streptococcus pneumoniae, and Neisseria meningitidis.

The increase in use of conjugate vaccines for adults, rise in number of regulatory approvals for conjugate vaccines, growth in prevalence of diseases caused by microorganisms such as Streptococcus pneumoniae and Neisseria meningitidis, and technological advancements majorly drive the growth of the market. In contrast, low accessibility to vaccines in remote areas and complex production procedure of conjugate vaccine restraint the market growth.

The worldwide market for Conjugate Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Novartis

- Neuron Biotech

- Serum Institute of India

- Pfizer

- Sanofi Pasteur

- Bharat Biotech

- Biological

- GlaxoSmithKline

- Merck

- CSL

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Monovalent Conjugate Vaccines

- Multivalent Conjugate Vaccines

Market Segment by Applications, can be divided into

- Pediatrics

- Adults

There are 15 Chapters to deeply display the global Conjugate Vaccines market.

Chapter 1, to describe Conjugate Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Conjugate Vaccines, with sales, revenue, and price of Conjugate Vaccines, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Conjugate Vaccines, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Conjugate Vaccines market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Conjugate Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Conjugate Vaccines Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Conjugate Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Monovalent Conjugate Vaccines
1.2.2 Multivalent Conjugate Vaccines
1.3 Market Analysis by Applications
1.3.1 Pediatrics
1.3.2 Adults
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Business Overview
2.1.2 Conjugate Vaccines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Neuron Biotech
2.2.1 Business Overview
2.2.2 Conjugate Vaccines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Neuron Biotech Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Serum Institute of India
2.3.1 Business Overview
2.3.2 Conjugate Vaccines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Serum Institute of India Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Conjugate Vaccines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sanofi Pasteur
2.5.1 Business Overview
2.5.2 Conjugate Vaccines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sanofi Pasteur Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bharat Biotech
2.6.1 Business Overview
2.6.2 Conjugate Vaccines Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bharat Biotech Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Biological
2.7.1 Business Overview
2.7.2 Conjugate Vaccines Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Biological Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 GlaxoSmithKline
2.8.1 Business Overview
2.8.2 Conjugate Vaccines Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 GlaxoSmithKline Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Merck
2.9.1 Business Overview
2.9.2 Conjugate Vaccines Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Merck Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 CSL
2.10.1 Business Overview
2.10.2 Conjugate Vaccines Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 CSL Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Conjugate Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Conjugate Vaccines Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Conjugate Vaccines Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Conjugate Vaccines Manufacturer Market Share in 2017
3.3.2 Top 6 Conjugate Vaccines Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Conjugate Vaccines Market Analysis by Regions
4.1 Global Conjugate Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global Conjugate Vaccines Sales and Market Share by Regions (2013-2018)
4.1.2 Global Conjugate Vaccines Revenue and Market Share by Regions (2013-2018)
4.2 North America Conjugate Vaccines Sales and Growth Rate (2013-2018)
4.3 Europe Conjugate Vaccines Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Conjugate Vaccines Sales and Growth Rate (2013-2018)
4.5 South America Conjugate Vaccines Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Conjugate Vaccines Sales and Growth Rate (2013-2018)
5 North America Conjugate Vaccines by Countries
5.1 North America Conjugate Vaccines Sales, Revenue and Market Share by Countries
5.1.1 North America Conjugate Vaccines Sales and Market Share by Countries (2013-2018)
5.1.2 North America Conjugate Vaccines Revenue and Market Share by Countries (2013-2018)
5.2 United States Conjugate Vaccines Sales and Growth Rate (2013-2018)
5.3 Canada Conjugate Vaccines Sales and Growth Rate (2013-2018)
5.4 Mexico Conjugate Vaccines Sales and Growth Rate (2013-2018)
6 Europe Conjugate Vaccines by Countries
6.1 Europe Conjugate Vaccines Sales, Revenue and Market Share by Countries
6.1.1 Europe Conjugate Vaccines Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Conjugate Vaccines Revenue and Market Share by Countries (2013-2018)
6.2 Germany Conjugate Vaccines Sales and Growth Rate (2013-2018)
6.3 UK Conjugate Vaccines Sales and Growth Rate (2013-2018)
6.4 France Conjugate Vaccines Sales and Growth Rate (2013-2018)
6.5 Russia Conjugate Vaccines Sales and Growth Rate (2013-2018)
6.6 Italy Conjugate Vaccines Sales and Growth Rate (2013-2018)
7 Asia-Pacific Conjugate Vaccines by Countries
7.1 Asia-Pacific Conjugate Vaccines Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Conjugate Vaccines Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Conjugate Vaccines Revenue and Market Share by Countries (2013-2018)
7.2 China Conjugate Vaccines Sales and Growth Rate (2013-2018)
7.3 Japan Conjugate Vaccines Sales and Growth Rate (2013-2018)
7.4 Korea Conjugate Vaccines Sales and Growth Rate (2013-2018)
7.5 India Conjugate Vaccines Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Conjugate Vaccines Sales and Growth Rate (2013-2018)
8 South America Conjugate Vaccines by Countries
8.1 South America Conjugate Vaccines Sales, Revenue and Market Share by Countries
8.1.1 South America Conjugate Vaccines Sales and Market Share by Countries (2013-2018)
8.1.2 South America Conjugate Vaccines Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Conjugate Vaccines Sales and Growth Rate (2013-2018)
8.3 Argentina Conjugate Vaccines Sales and Growth Rate (2013-2018)
8.4 Colombia Conjugate Vaccines Sales and Growth Rate (2013-2018)
9 Middle East and Africa Conjugate Vaccines by Countries
9.1 Middle East and Africa Conjugate Vaccines Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Conjugate Vaccines Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Conjugate Vaccines Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Conjugate Vaccines Sales and Growth Rate (2013-2018)
9.3 UAE Conjugate Vaccines Sales and Growth Rate (2013-2018)
9.4 Egypt Conjugate Vaccines Sales and Growth Rate (2013-2018)
9.5 Nigeria Conjugate Vaccines Sales and Growth Rate (2013-2018)
9.6 South Africa Conjugate Vaccines Sales and Growth Rate (2013-2018)
10 Global Conjugate Vaccines Market Segment by Type
10.1 Global Conjugate Vaccines Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Conjugate Vaccines Sales and Market Share by Type (2013-2018)
10.1.2 Global Conjugate Vaccines Revenue and Market Share by Type (2013-2018)
10.2 Monovalent Conjugate Vaccines Sales Growth and Price
10.2.1 Global Monovalent Conjugate Vaccines Sales Growth (2013-2018)
10.2.2 Global Monovalent Conjugate Vaccines Price (2013-2018)
10.3 Multivalent Conjugate Vaccines Sales Growth and Price
10.3.1 Global Multivalent Conjugate Vaccines Sales Growth (2013-2018)
10.3.2 Global Multivalent Conjugate Vaccines Price (2013-2018)
11 Global Conjugate Vaccines Market Segment by Application
11.1 Global Conjugate Vaccines Sales Market Share by Application (2013-2018)
11.2 Pediatrics Sales Growth (2013-2018)
11.3 Adults Sales Growth (2013-2018)
12 Conjugate Vaccines Market Forecast (2018-2023)
12.1 Global Conjugate Vaccines Sales, Revenue and Growth Rate (2018-2023)
12.2 Conjugate Vaccines Market Forecast by Regions (2018-2023)
12.2.1 North America Conjugate Vaccines Market Forecast (2018-2023)
12.2.2 Europe Conjugate Vaccines Market Forecast (2018-2023)
12.2.3 Asia-Pacific Conjugate Vaccines Market Forecast (2018-2023)
12.2.4 South America Conjugate Vaccines Market Forecast (2018-2023)
12.2.5 Middle East and Africa Conjugate Vaccines Market Forecast (2018-2023)
12.3 Conjugate Vaccines Market Forecast by Type (2018-2023)
12.3.1 Global Conjugate Vaccines Sales Forecast by Type (2018-2023)
12.3.2 Global Conjugate Vaccines Market Share Forecast by Type (2018-2023)
12.4 Conjugate Vaccines Market Forecast by Application (2018-2023)
12.4.1 Global Conjugate Vaccines Sales Forecast by Application (2018-2023)
12.4.2 Global Conjugate Vaccines Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Conjugate Vaccines Picture
Table Product Specifications of Conjugate Vaccines
Figure Global Sales Market Share of Conjugate Vaccines by Types in 2017
Table Conjugate Vaccines Types for Major Manufacturers
Figure Monovalent Conjugate Vaccines Picture
Figure Multivalent Conjugate Vaccines Picture
Figure Conjugate Vaccines Sales Market Share by Applications in 2017
Figure Pediatrics Picture
Figure Adults Picture
Figure United States Conjugate Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Conjugate Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Conjugate Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Conjugate Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure France Conjugate Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure UK Conjugate Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Conjugate Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Conjugate Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure China Conjugate Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Conjugate Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Conjugate Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure India Conjugate Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Conjugate Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Conjugate Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Conjugate Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Conjugate Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Conjugate Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Conjugate Vaccines Revenue (Value) and Growth Rate (2013-2023)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Conjugate Vaccines Type and Applications
Table Novartis Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Neuron Biotech Basic Information, Manufacturing Base and Competitors
Table Neuron Biotech Conjugate Vaccines Type and Applications
Table Neuron Biotech Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table Serum Institute of India Conjugate Vaccines Type and Applications
Table Serum Institute of India Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Conjugate Vaccines Type and Applications
Table Pfizer Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table Sanofi Pasteur Conjugate Vaccines Type and Applications
Table Sanofi Pasteur Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table Bharat Biotech Conjugate Vaccines Type and Applications
Table Bharat Biotech Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biological Basic Information, Manufacturing Base and Competitors
Table Biological Conjugate Vaccines Type and Applications
Table Biological Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Conjugate Vaccines Type and Applications
Table GlaxoSmithKline Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Conjugate Vaccines Type and Applications
Table Merck Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CSL Basic Information, Manufacturing Base and Competitors
Table CSL Conjugate Vaccines Type and Applications
Table CSL Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Conjugate Vaccines Sales by Manufacturer (2016-2017)
Figure Global Conjugate Vaccines Sales Market Share by Manufacturer in 2016
Figure Global Conjugate Vaccines Sales Market Share by Manufacturer in 2017
Table Global Conjugate Vaccines Revenue by Manufacturer (2016-2017)
Figure Global Conjugate Vaccines Revenue Market Share by Manufacturer in 2016
Figure Global Conjugate Vaccines Revenue Market Share by Manufacturer in 2017
Figure Top 3 Conjugate Vaccines Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Conjugate Vaccines Manufacturer (Revenue) Market Share in 2017
Figure Global Conjugate Vaccines Sales and Growth Rate (2013-2018)
Figure Global Conjugate Vaccines Revenue and Growth Rate (2013-2018)
Table Global Conjugate Vaccines Sales by Regions (2013-2018)
Table Global Conjugate Vaccines Sales Market Share by Regions (2013-2018)
Table Global Conjugate Vaccines Revenue by Regions (2013-2018)
Figure Global Conjugate Vaccines Revenue Market Share by Regions in 2013
Figure Global Conjugate Vaccines Revenue Market Share by Regions in 2017
Figure North America Conjugate Vaccines Sales and Growth Rate (2013-2018)
Figure Europe Conjugate Vaccines Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Conjugate Vaccines Sales and Growth Rate (2013-2018)
Figure South America Conjugate Vaccines Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Conjugate Vaccines Sales and Growth Rate (2013-2018)
Figure North America Conjugate Vaccines Revenue and Growth Rate (2013-2018)
Table North America Conjugate Vaccines Sales by Countries (2013-2018)
Table North America Conjugate Vaccines Sales Market Share by Countries (2013-2018)
Figure North America Conjugate Vaccines Sales Market Share by Countries in 2013
Figure North America Conjugate Vaccines Sales Market Share by Countries in 2017
Table North America Conjugate Vaccines Revenue by Countries (2013-2018)
Table North America Conjugate Vaccines Revenue Market Share by Countries (2013-2018)
Figure North America Conjugate Vaccines Revenue Market Share by Countries in 2013
Figure North America Conjugate Vaccines Revenue Market Share by Countries in 2017
Figure United States Conjugate Vaccines Sales and Growth Rate (2013-2018)
Figure Canada Conjugate Vaccines Sales and Growth Rate (2013-2018)
Figure Mexico Conjugate Vaccines Sales and Growth Rate (2013-2018)
Figure Europe Conjugate Vaccines Revenue and Growth Rate (2013-2018)
Table Europe Conjugate Vaccines Sales by Countries (2013-2018)
Table Europe Conjugate Vaccines Sales Market Share by Countries (2013-2018)
Table Europe Conjugate Vaccines Revenue by Countries (2013-2018)
Figure Europe Conjugate Vaccines Revenue Market Share by Countries in 2016
Figure Europe Conjugate Vaccines Revenue Market Share by Countries in 2017
Figure Germany Conjugate Vaccines Sales and Growth Rate (2013-2018)
Figure UK Conjugate Vaccines Sales and Growth Rate (2013-2018)
Figure France Conjugate Vaccines Sales and Growth Rate (2013-2018)
Figure Russia Conjugate Vaccines Sales and Growth Rate (2013-2018)
Figure Italy Conjugate Vaccines Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Conjugate Vaccines Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Conjugate Vaccines Sales by Countries (2013-2018)
Table Asia-Pacific Conjugate Vaccines Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Conjugate Vaccines Sales Market Share by Countries 2017
Table Asia-Pacific Conjugate Vaccines Revenue by Countries (2013-2018)
Figure Asia-Pacific Conjugate Vaccines Revenue Market Share by Countries 2017
Figure China Conjugate Vaccines Sales and Growth Rate (2013-2018)
Figure Japan Conjugate Vaccines Sales and Growth Rate (2013-2018)
Figure Korea Conjugate Vaccines Sales and Growth Rate (2013-2018)
Figure India Conjugate Vaccines Sales and Growth Rate (2013-2018)
Figure Southeast Asia Conjugate Vaccines Sales and Growth Rate (2013-2018)
Figure South America Conjugate Vaccines Revenue and Growth Rate (2013-2018)
Table South America Conjugate Vaccines Sales by Countries (2013-2018)
Table South America Conjugate Vaccines Sales Market Share by Countries (2013-2018)
Figure South America Conjugate Vaccines Sales Market Share by Countries in 2017
Table South America Conjugate Vaccines Revenue by Countries (2013-2018)
Table South America Conjugate Vaccines Revenue Market Share by Countries (2013-2018)
Figure South America Conjugate Vaccines Revenue Market Share by Countries in 2017
Figure Brazil Conjugate Vaccines Sales and Growth Rate (2013-2018)
Figure Argentina Conjugate Vaccines Sales and Growth Rate (2013-2018)
Figure Colombia Conjugate Vaccines Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Conjugate Vaccines Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Conjugate Vaccines Sales by Countries (2013-2018)
Table Middle East and Africa Conjugate Vaccines Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Conjugate Vaccines Sales Market Share by Countries in 2017
Table Middle East and Africa Conjugate Vaccines Revenue by Countries (2013-2018)
Table Middle East and Africa Conjugate Vaccines Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Conjugate Vaccines Revenue Market Share by Countries in 2013
Figure Middle East and Africa Conjugate Vaccines Revenue Market Share by Countries in 2017
Figure Saudi Arabia Conjugate Vaccines Sales and Growth Rate (2013-2018)
Figure UAE Conjugate Vaccines Sales and Growth Rate (2013-2018)
Figure Egypt Conjugate Vaccines Sales and Growth Rate (2013-2018)
Figure Nigeria Conjugate Vaccines Sales and Growth Rate (2013-2018)
Figure South Africa Conjugate Vaccines Sales and Growth Rate (2013-2018)
Table Global Conjugate Vaccines Sales by Type (2013-2018)
Table Global Conjugate Vaccines Sales Share by Type (2013-2018)
Table Global Conjugate Vaccines Revenue by Type (2013-2018)
Table Global Conjugate Vaccines Revenue Share by Type (2013-2018)
Figure Global Monovalent Conjugate Vaccines Sales Growth (2013-2018)
Figure Global Monovalent Conjugate Vaccines Price (2013-2018)
Figure Global Multivalent Conjugate Vaccines Sales Growth (2013-2018)
Figure Global Multivalent Conjugate Vaccines Price (2013-2018)
Table Global Conjugate Vaccines Sales by Application (2013-2018)
Table Global Conjugate Vaccines Sales Share by Application (2013-2018)
Figure Global Adults Sales Growth (2013-2018)
Figure Global Conjugate Vaccines Sales, Revenue and Growth Rate (2018-2023)
Table Global Conjugate Vaccines Sales Forecast by Regions (2018-2023)
Table Global Conjugate Vaccines Market Share Forecast by Regions (2018-2023)
Figure North America Sales Conjugate Vaccines Market Forecast (2018-2023)
Figure Europe Sales Conjugate Vaccines Market Forecast (2018-2023)
Figure Asia-Pacific Sales Conjugate Vaccines Market Forecast (2018-2023)
Figure South America Sales Conjugate Vaccines Market Forecast (2018-2023)
Figure Middle East and Africa Sales Conjugate Vaccines Market Forecast (2018-2023)
Table Global Conjugate Vaccines Sales Forecast by Type (2018-2023)
Table Global Conjugate Vaccines Market Share Forecast by Type (2018-2023)
Table Global Conjugate Vaccines Sales Forecast by Application (2018-2023)
Table Global Conjugate Vaccines Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global Hip Replacement Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 15-Nov-2018        Price: US 3480 Onwards        Pages: 116
    Hip replacement is a surgical procedure in which the hip joint is replaced by a prosthetic implant, that is, a hip prosthesis. Hip replacement surgery can be performed as a total replacement or a hemi replacement. Scope of the Report: The demand of hip replacement implant will steadfast growth in the coming years. The surging demand for hip replacement surgeries coupled with rising clinical awareness among patients is fuelling the hip replacement implant market. Increasing ......
  • Global Hip Resurfacing Implants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 15-Nov-2018        Price: US 3480 Onwards        Pages: 135
    Hip resurfacing is a technique designed to reline the worn out joint, instead of being replaced completely as in total hip replacement procedure. In hip resurfacing the femoral head is not removed, instead it is trimmed and resurfaced with smooth metal covering. Scope of the Report: Hip resurfacing creates bigger hip ball than generally used in hip replacement, which reduces the risk of dislocation. Hip resurfacing provide active and improved quality of life which is done b......
  • Global Histoplasmosis Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 15-Nov-2018        Price: US 3480 Onwards        Pages: 121
    Histoplasmosis is an infection that occurs from breathing spores of a fungus called Histoplasma capsulatum. Histoplasmosis is a fungal infection that occurs throughout the world. Histoplasma fungus grows as a mold in the soil. The soil that contains the droppings of bat or birds usually contains large amount of this fungus. The people with weakened immune system are usually more prone and increases the risk of being affected or reactivated with histoplasmosis. Usually people very young, old peop......
  • Global HIV Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 15-Nov-2018        Price: US 3480 Onwards        Pages: 121
    The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss of ability to fight against the organism that causes disease. Scope of the Report: HIV spreads through fluidic exchange with some infected person such as blood transfer or sharing needles with someone who is HIV infected. In addition, HIV can spread from infected moth......
  • Global HIV-AIDS Testing Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 15-Nov-2018        Price: US 3480 Onwards        Pages: 136
    HIV-AIDS is a chronic disease caused by the human immunodeficiency virus (HIV). HIV virus damages human immune system, which results weakness of immune system and loss ability to fight with organism that causes disease. HIV-AIDS most often spread through unprotected sex with HIV infected person. In addition, HIV-AIDS can also be spread from infected mother to child during pregnancy, infected blood and sharing needles with someone who has HIV-AIDS. Some of the symptoms of HIV inclu......
  • Global Home Infusion Therapy Devices Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 15-Nov-2018        Price: US 3480 Onwards        Pages: 121
    Home infusion therapy facilitates the intravenous administration of medicines into the body of a patient with a needle or catheter. It is prescribed by physicians and administered by trained professionals and nurses. It is used when oral medication is not effective for the treatment of diseases. It reduces the time spent by patients in hospitals, nursing homes and clinics. It includes continuous and slow administration of drugs, antibiotics, nutrients and other fluids into the veins on a daily, ......
  • Global Home Infusion Therapy Services Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 15-Nov-2018        Price: US 3480 Onwards        Pages: 119
    Home infusion therapy services offer an innovative healthcare services at the doorsteps. Infusion therapy administer medication through needle or a catheter. Infusion therapy is generally used when the patient's condition is very severe and cannot be cured with the oral medication. Home infusion is best described as most convenient for patient particularly when the infusion is needed multiple times in a day or long term care. Disease which need infusion therapies include cancer and cancer relate......
  • Global Hormone Refractory Prostate Cancer Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 15-Nov-2018        Price: US 3480 Onwards        Pages: 100
    Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, intensifying HRPCA prevalence and fast-emerging treatment modifications, the global HRPCA market is poised to witness an unprecedented growth. Scope of the Report: The global Hor......
  • Global Hospice Services Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 15-Nov-2018        Price: US 3480 Onwards        Pages: 115
    Hospice services are cost-effective humane and compassionate care services provided to the patients who are in the last phase of their life and have completed the medical treatment course for incurable diseases such as congestive heart failure, cancer, dementia and lung disease. These services focus on the quality of the life instead of its length so that patients may live with maximum comfort in their last days. Scope of the Report: Usually hospice services are used when a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs